Cardiology Confab Roundup: Drugs, Stents More
Sarah Rubenstein
While you were relaxing over the weekend, cardiologists were busy soaking in the results from a bunch of studies presented at the annual meeting of the American College of Cardiology. Here are some highlights.
There was more good news for AstraZeneca out of its Jupiter study of the cholesterol-lowering drug Crestor. The drug […]